VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics

BACKGROUND: A new class of antiretrovirals, AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs), has been proposed as a disease-modifying therapy to both reduce Human Immunodeficiency Virus Type 1 (HIV-1) RNA levels and the excessive immune activation now recognized as the major driver of not...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Lori, Franco, De Forni, Davide, Katabira, Elly, Baev, Denis, Maserati, Renato, Calarota, Sandra A., Cahn, Pedro, Testori, Marco, Rakhmanova, Aza, Stevens, Michael R.
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2012
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477169/
https://ncbi.nlm.nih.gov/pubmed/23094055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047485
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker